Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ONXX -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (299)	4/15/1999 7:53:00 AM
From: Dan Gorman	Respond to of 810

Watch out!!! ONXX makes NY Times Online nytimes.com

To: Mike McFarland who wrote (299)	4/15/1999 10:26:00 AM
From: scaram(o)uche	Read Replies (2) \| Respond to of 810

This is hilarious..... daytraders see a potential new treatment for several if not all solid tumors, and they're making a stand around a research premium of about 60 million and a market cap of about 94 million. Jeeeeeez, either take it to $4 or $20 plus..... take it to the value with Bayer and Ras alone or take it to something respectable, don't mess around at these piddly levels. Insane. The third-tier has been so beaten on that nobody knows a rational valuation any longer.